← Leaderboards
Adrienne D Cox
University Of North Carolina Chapel Hill
$5,471,068
Attributed
$7,023,602
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2005–24$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$7,023,602 · 8
By mechanism
U01$2,457,493 · 1
T32$2,246,675 · 2
R01$1,324,536 · 2
P01$777,301 · 1
U19$209,597 · 1
R13$8,000 · 1
Top collaborators
- Channing J Der7 shared
Most similar at University Of North Carolina Chapel Hill
Same institution · by research overlap
- Channing J Der$34,774,720
- Shoji Osawa$493,380
Others in their field
Top investigators on “Cancer Cell”
- David Heimbrook · Leidos Biomedical Research, Inc.$394,493,843
- Gregory H Reaman · National Childhood Cancer Foundation$172,801,935
- Richard A Gibbs · Baylor College Of Medicine$159,160,442
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Mary M Horowitz · Medical College Of Wisconsin$153,900,671
- William George Nelson · Johns Hopkins University$111,434,918
Research focus
Cancer CellProteinsPropertyBaseGrowthSignal TransductionPathway InteractionsMutationAllelesMalignant Neoplasm Of PancreasPhenotypeMalignant NeoplasmsCell LineMutantInnovationGain Of FunctionGenetic ScreeningKras2 GeneAddictionCollaborationsSignal PathwayMeksCellular BiologyTraining Programs
Grant awards (28)
Cancer Cell Biology Training Program$332,856
T32 · FY2024 · CA
Cancer Cell Biology Training Program$314,720
T32 · FY2023 · CA
Cancer Cell Biology Training Program$235,562
T32 · FY2021 · CA · contact PI
Cancer Cell Biology Training Program$147,058
T32 · FY2020 · CA · contact PI
Project 3: Mechanisms and therapeutic targeting of NRAS in melanoma$143,966
P01 · FY2020 · CA · contact PI
Identification of synthetic lethal interactors in pancreatic cancer$323,651
U01 · FY2019 · CA
Cancer Cell Biology Training Program$234,992
T32 · FY2019 · CA · contact PI
Project 3: Mechanisms and therapeutic targeting of NRAS in melanoma$193,258
P01 · FY2019 · CA · contact PI
Identification of synthetic lethal interactors in pancreatic cancer$316,801
U01 · FY2018 · CA
Cancer Cell Biology Training Program$147,378
T32 · FY2018 · CA · contact PI
Project 3: Mechanisms and therapeutic targeting of NRAS in melanoma$144,036
P01 · FY2018 · CA · contact PI
Identification of synthetic lethal interactors in pancreatic cancer$340,086
U01 · FY2017 · CA
Cancer Cell Biology Training Program$167,026
T32 · FY2017 · CA · contact PI
Project 3: Mechanisms and therapeutic targeting of NRAS in melanoma$144,071
P01 · FY2017 · CA · contact PI
Identification of synthetic lethal interactors in pancreatic cancer$732,247
U01 · FY2016 · CA
Cancer Cell Biology Training Program$205,844
T32 · FY2016 · CA · contact PI
Project 3: Mechanisms and therapeutic targeting of NRAS in melanoma$151,970
P01 · FY2016 · CA · contact PI
Identification of synthetic lethal interactors in pancreatic cancer$744,708
U01 · FY2015 · CA
Protein prenylation, oncogenesis and novel therapeutics$225,514
R01 · FY2008 · CA · contact PI
Cell and Molocular Biology Training Grant$203,858
T32 · FY2008 · GM · contact PI
Cell and Molocular Biology Training Grant$257,381
T32 · FY2007 · GM · contact PI
Protein prenylation, oncogenesis and novel therapeutics$225,514
R01 · FY2007 · CA · contact PI
Protein prenylation, oncogenesis and novel therapeutics$232,249
R01 · FY2006 · CA · contact PI
Regulation & Function of Small GTPases$8,000
R13 · FY2006 · CA · contact PI
Protein prenylation, oncogenesis and novel therapeutics$237,838
R01 · FY2005 · CA
VALIDATION OF INHIBITORS OF RHO GTPASES FOR CANCER TREATMENT$209,597
U19 · FY2005 · CA
Protein prenylation, oncogenesis and novel therapeutics$233,311
R01 · FY2004 · CA
MECHANISM OF FTI ACTION AND K-RAS INHIBITION$170,110
R01 · FY2000 · CA